We welcome the letter by Finsterer (1) in response to our article: Encephalitis Associated With SARS-CoV-2 Infection in a Child With Chiari Malformation Type I (2). Finsterer raised 10 points to be clarified or discussed. Hence, we appreciate the opportunity to provide additional insights into our case report.The first point concerns the triad of SARS-CoV-2 infection, oral ulcerations and odynophagia. Although rare, oral ulcerations and odynophagia have been described in patients with . There is a broad discussion about the etiology of oral manifestations of COVID-19, which might be attributed to (i) the direct or indirect action of SARS-CoV-2 on oral mucosal cells; (ii) other pathogens such as viruses; and (iii) immunodepression (6-8). SARS-CoV-2 has tropism to the tongue (keratinized and nonkeratinized mucosa) and salivary gland epithelium due to the expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) receptors in oral mucosa epithelia (7-10). In this regard, studies suggest that the interaction between SARS-CoV-2 and their receptors could potentially disrupt the function of oral keratinocytes resulting in odynophagia and oral mucosal ulcerations (3-5). Furthermore, Brandão et al. observed that the evolution of oral ulcerations and the healing process occurred in parallel with the resolution of COVID-19 (4). Nevertheless, one limitation of our study was the lack of robust validation, such as by including an incisional biopsy, followed by reverse-transcription polymerase chain reaction testing for SARS-CoV-2 and immunohistochemistry to evaluate ACE2 and TMPRSS2 expression. For sure, a differential diagnosis would also have been helpful to rule out other pathogens, diseases, or drugs associated with the oral ulcerations. We were not able to eliminate other possibilities due to the family's economic limitations and the financing aspects of the institution.The second point is regarding Chiari-I malformation and how SARS-CoV-2 entered the central nervous system. In our article, the presentation of encephalitis associated with COVID-19 in a patient with Chiari malformation type I was reported (2). Although this remark seems trivial, it is necessary to emphasize that we are not talking about the causal relationship between Chiari malformation type I and the development of SARS-CoV-2-related encephalitis, but only about possible implications for the health of the patient with this congenital syndrome and coronavirus-related encephalitis. Recently, Brugliera et al. reported a novel case involving therapy for pain management in a patient with Chiari malformation type I during concomitant SARS-COV-2 infection (11). Thus, our findings also expanded the understanding of clinicians' different challenges.Regarding the entry of SARS-CoV-2 into the central nervous system (CNS), these mechanisms were discussed in our case study (2). Jakhmola et al. summarized the mode of action and brain or cerebrospinal fluid (CSF)/plasma ratio of antivirals with properties of high bioavailability ...